Pure Global AI
NCT06352125Completed

An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge

Haemonetics CorporationClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Surgery
Drug/Device/Intervention
TEG 6s Citrated K, KH, RTH, FFH Cartridge
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Haemonetics Corporation
Location
San Francisco,Aurora,New Orleans,Baltimore,Boston,Pittsburgh,San Antonio, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 09, 2021
End date
Jan 31, 2023
Enrollment
338 participants
Primary outcome

Primary Method Comparison,Primary Method Comparison,Primary Method Comparison,Primary Method Comparison,Primary Method Comparison,Primary Method Comparison,Primary Method Comparison

Summary

This clinical trial is designed to assess the agreement of the TEG® 6s system using the
 Citrated K, KH, RTH, FFH, cartridge (hereafter referred to as the Heparin Neutralization (HN)
 Cartridge) with its comparators.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06352125
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06352125 through Pure Global AI's free database. This phase not specified trial is sponsored by Haemonetics Corporation and is currently Completed. The study focuses on Surgery. Target enrollment is 338 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.